Climb Bio, Inc. (CLYM)
6.94
-0.13
(-1.84%)
USD |
NASDAQ |
Mar 03, 09:56
Climb Bio Cash from Investing (Quarterly) : 15.26M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -288.10M |
| Fortress Biotech, Inc. | 2.87M |
| Oramed Pharmaceuticals, Inc. | 38.82M |
| Lyell Immunopharma, Inc. | 3.349M |
| PepGen Inc. | 18.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.14M |
| Free Cash Flow | -44.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1801 |
| Free Cash Flow to Equity (Quarterly) | -12.19M |
| Free Cash Flow to Firm (Quarterly) | -12.25M |
| Free Cash Flow Yield | -9.47% |